Stempoint Capital »

Zura Bio shares owned by Stempoint Capital

Quarter-by-quarter ownership of Zura Bio (ZURA) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Zura Bio

Tip: Access up to 7 years of quarterly data

All positions including Zura Bio held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zura Bio by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.2M 1.0M 4.06

More positions owned by Stempoint Capital

Syndax Pharmaceuticals (SNDX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Merus N V (MRUS)
Arcutis Biotherapeutics (ARQT)
Amicus Therapeutics (FOLD)
Applied Therapeutics (APLT)
Bristol Myers Squibb (BMY)
Crinetics Pharmaceuticals In (CRNX)
Biohaven (BHVN)
Praxis Precision Medicines I Com New (PRAX)
Autolus Therapeutics Spon Ads (AUTL)
Incyte Corporation (INCY)
Denali Therapeutics (DNLI)
Day One Biopharmaceuticals I (DAWN)

View all positions for Stempoint Capital

Top funds holding Zura Bio

Suvretta Capital Management
Deep Track Capital
Dr. Jeffrey R. Jay, M.D.
RA Capital Management
Armistice Capital
Braidwell
Point72 Asset Management
BlackRock
VR Adviser
BlackRock
Stempoint Capital
Geode Capital Management
Vanguard Group
Woodline Partners
Caption Management

View all funds holding Zura Bio